Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- AR1001Phase 31 trial
AriBio Co., Ltd. · Alzheimer Disease
- arboplatinPhase 31 trial
Hansoh BioMedical R&D Company · Platinum-sensitive Recurrent Ovarian Cancer
- ASI-02Phase 31 trial
Agitated Solutions, Inc. · Right-To-Left Shunt
- ASP2138Phase 31 trial
Astellas · Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma
- ASTX030cedazuridine + azacitidinePhase 31 trial
Taiho Oncology, Inc. · Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm
- ATB-1011Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1012Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1013Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- Atezolizumab followed by AtezolizumabPhase 31 trial
SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma
- Atigotatug+NivolumabBMS-986489Phase 31 trial
Bristol Myers Squibb · Extensive-Stage Small Cell Lung Cancer
- ATSN-201Phase 31 trial
Atsena Therapeutics Inc. · X-linked Retinoschisis
- Avexitideexendin 9-39Phase 31 trial
Amylyx Pharmaceuticals Inc. · Post Bariatric Hypoglycemia
- AVT29proposed aflibercept HD biosimilarPhase 31 trial
Alvotech Swiss AG · Diabetic Macular Edema
- AXS-07meloxicam-rizatriptanPhase 31 trial
Axsome Therapeutics, Inc. · Migraine
- B001Phase 31 trial
Shanghai Jiaolian Drug Research and Development Co., Ltd · Neuromyelitis Optica Spectrum Disorders
- B2227Phase 31 trial
Bostal Drug Delivery Co., Ltd · Schizophrenia
- BAT1706Phase 31 trial
BeOne Medicines (BeiGene) · Advanced Malignancies
- BCD-131pegdarbepoetin betaPhase 31 trial
Biocad · Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis
- BCD-281Phase 31 trial
Biocad · Relapsing-remitting Multiple Sclerosis (RRMS)
- BE11164F-PCCPhase 31 trial
CSL Behring · Complex Cardiovascular Surgery With Cardiopulmonary Bypass
- BecavizumabPhase 31 trial
Roche (Genentech) · Hepatocellular Carcinoma
- BemarituzumabPhase 31 trial
Amgen · Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
- bemdaneprocelMSK-DA01, BRT-DA01Phase 31 trial
BlueRock Therapeutics · Parkinsons Disease (PD)
- BERLIM 2520 ASSOCIATIONPhase 31 trial
EMS · Dyslipidemia Associated With Type II Diabetes Mellitus
- BGB-43395Phase 31 trial
BeOne Medicines (BeiGene) · HR+/HER2- Breast Cancer
- BHV-1400Phase 31 trial
Biohaven Therapeutics Ltd. · IgA Nephropathy
- BHV-8000Phase 31 trial
Biohaven Therapeutics Ltd. · Parkinson Disease
- BK1803Phase 31 trial
Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus
- BLI5100Phase 31 trial
Braintree Laboratories · Erosive Esophagitis
- Blinded EnvudeucitinibPhase 31 trial
Alumis Inc · Plaque Psoriasis, Psoriasis (PsO), Psoriasis
- BMN 333Phase 31 trial
BioMarin · Achondroplasia
- BMS-663068Phase 31 trial
GSK · HIV Infections
- BMS-986365Phase 31 trial
Bristol Myers Squibb · Metastatic Castration-resistant Prostate Cancer
- BNC210Phase 31 trial
Bionomics Limited · Social Anxiety Disorder
- BNT113Phase 31 trial
BioNTech SE · Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer
- BR1018APhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018A-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018BPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018B-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018CPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018C-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1019APhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019A-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019BPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019B-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019CPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019C-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BRC-201TG-1000, Pixavir MarboxilPhase 31 trial
Boryung Biopharma Co., Ltd. · Influenza
- Buparlisib & PaclitaxelAN2025Phase 31 trial
Adlai Nortye Biopharma Co., Ltd. · Head and Neck Cancer
- Bupropion Sustained-ReleasePhase 31 trial
CSPC Ouyi Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.